OOIR: Observatory of International Research

Papers

(The TQCC of Critical Reviews in Microbiology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Male-specific bacteriophages and their potential on combating the spreading of T4SS-bearing antimicrobial resistance plasmids	145
Neuroinflammation-mediated relationship between oral microbiome and neurodegenerative diseases	75
Dynamics of antibiotic resistance genes in plasmids and bacteriophages	66
TREM-2: friend or foe in infectious diseases?	65
EnterohepaticHelicobacterspecies – clinical importance, host range, and zoonotic potential	56
Salmonella in eggs and egg-laying chickens: pathways to effective control	52
Helicobacter pylori infection: from standard to alternative treatment strategies	42
Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapies	40
Paving the way forward: Escherichia coli bacteriophages in a One Health approach	37
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases	36
Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens	36
Targeting bioinformatics tools to study the dissemination and spread of antibiotic resistant genes in the environment and clinical settings	33
The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19	33
Relevance of organ(s)-on-a-chip systems to the investigation of food-gut microbiota-host interactions	32
Outer membrane proteins and vesicles as promising vaccine candidates against Vibrio spp. infections	32
Biosynthesis, regulation, and biological significance of fumonisins in fungi: current status and prospects	30
Antibiotic heteroresistance: an important factor in the failure of Helicobacter Pylori eradication	29
Applications of bacteriophages against intracellular bacteria	27
Exploring halophilic environments as a source of new antibiotics	27
LysR-type transcriptional regulators: state of the art	27
Vibrio cholerae virulence and its suppression through the quorum-sensing system	26
Bile acid–gut microbiota crosstalk in irritable bowel syndrome	26
Interplay between Clostridioides difficile infection, host immunity, and metabolism: a comprehensive review	25
Biofilm formation in clinically relevant filamentous fungi: a therapeutic challenge	25
Emerging cellular and molecular interactions between the lung microbiota and lung diseases	24

The microbiome and precision oncology: an emerging paradigm in anticancer therapy	24
Advances in the applications of Bacteriophages and phage products against food-contaminating bacteria	24
The role of influenza A virus-induced hypercytokinemia	23
Polyamine as a microenvironment factor in resistance to antibiotics	23
Endophytic fungi-bioinspired nanoparticles potential to control infectious disease	22
The diffusible signaling factor family in microbial signaling: a current perspective	22
Building up a clinical microbiota profiling: a quality framework proposal	21
The role of single and mixed biofilms in Clostridioides difficile infection and strategies for prevention and inhibition	21
Probiotics for pancreatic β-cell function: from possible mechanism of action to assessment of effectiveness	21
Phage-bacterial evolutionary interactions: experimental models and complications	20
Emerging strategies to target virulence in Pseudomonas aeruginosa respiratory infections	19
Microbial persisters and host: recent advances and future perspectives	19
Antibiotic resistance in Pseudomonas aeruginosa : mechanisms and emerging treatment	18
Burkholderia in the genomic era: from taxonomy to the discovery of new antimicrobial secondary metabolites	18
Emergence of persister cells in Staphylococcus aureus : calculated or fortuitous move?	18
Multidrug-resistantTrichosporonspecies: underestimated fungal pathogens posing imminent threats in clinical settings	16
Ocular surface microbiota dysbiosis contributes to the high prevalence of dry eye disease in diabetic patients	16
Ureaplasma infections: update on epidemiology, antimicrobial resistance, and pathogenesis	16
Microbial biosynthesis of nucleos(t)ide analogs: applications, and engineering optimization	16
Current types of staphylococcal cassette chromosome mec (SCC mec ) in clinically relevant coagulase-negative staphylococcal (CoNS) species	15
Quorum sensing in biofilms: a key mechanism to target in ecotoxicological studies	15
Nanophotocatalysts against viruses and antibiotic-resistant bacteria: recent advances	14
Advances in mining and expressing microbial biosynthetic gene clusters	14
Porphyromonas gingivalis and the pathogenesis of Alzheimer’s disease	14
Bacillusspore-forming probiotics: benefits with concerns?	14
Review on computer-assisted biosynthetic capacities elucidation to assess metabolic interactions and communication within microbial communities	13
The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential	13
The potential for bacteriophages and prophage elements in fighting and preventing the gonorrhea	13
The crosstalk between SUMOylation and immune system in host-pathogen interactions	12
Community dynamics of subgingival microbiome in periodontitis and targets for microbiome modulation therapy	12